Recent Publications

Rationale and design of the granulocyte-macrophage colony stimulating factor in peripheral arterial disease (GPAD-3) study

Circulating stem cells and cardiovascular outcomes: from basic science to the clinic

Association Between Change in Circulating Progenitor Cells During Exercise Stress and Risk of Adverse Cardiovascular Events in Patients With Coronary Artery Disease

Circulating Progenitor Cells and Memory Function in Patients with Coronary Artery Disease

High-Sensitivity Troponin and Coronary Artery Disease Severity: A Bridge Too Far?

Progenitor Cells and Clinical Outcomes in Patients With Heart Failure

Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial

Flow cytometric data analysis of circulating progenitor cell stability.

PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI.

Bioactive Lipids and Circulating Progenitor Cells in Patients With Cardiovascular Disease.

Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD).

Age and Human Regenerative Capacity Impact of Cardiovascular Risk Factors.

Effect of storage-aged red blood cell transfusions on endothelial function in healthy subjects.

Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: etanercept, vascular function and endothelial progenitor cells in psoriasis.

Predictors of Response to Intracoronary Delivery of CD34+CXCR4+ Enriched Bone Marrow Derived Stem Cells (AMR-001) Early After STEMI